|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant liability | ||||||||||||||||
| Assets | ||||||||||||||||
| Current assets: | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||
| Research and development incentives receivables | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Property and equipment, net | ||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||
| Intangible assets, net | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Current liabilities: | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Accrued expenses | ||||||||||||||||
| Convertible loan notes - current | ||||||||||||||||
| Operating lease liabilities - current | ||||||||||||||||
| Warrant liabilities - current | ||||||||||||||||
| Other current liabilities | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Convertible loan notes - non-current | ||||||||||||||||
| Warrant liabilities - non-current | ||||||||||||||||
| Operating lease liabilities- non-current | ||||||||||||||||
| Other non-current liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Shareholders' Equity | ||||||||||||||||
| Ordinary shares, par value 0.003 per share; 798,454,864 shares issued at September 30, 2026 (December 31, 2025: 795,658,504) | ||||||||||||||||
| Treasury shares | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||
| Total shareholders' equity | ||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||
Loading...